logo
My Activity
Recently Viewed
You have not visited any articles yet, Please visit some articles to see contents here.
CONTENT TYPES

Light-Activated Core–Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer

  • Qingshuo Meng
    Qingshuo Meng
    State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    University of Chinese Academy of Sciences, Beijing 100049, China
  • Jia Meng
    Jia Meng
    State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    University of Chinese Academy of Sciences, Beijing 100049, China
    More by Jia Meng
  • Wei Ran
    Wei Ran
    State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    University of Chinese Academy of Sciences, Beijing 100049, China
    More by Wei Ran
  • Junyang Wang
    Junyang Wang
    State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    Jilin University, Changchun, Jilin 130012, China
    More by Junyang Wang
  • Yihui Zhai
    Yihui Zhai
    State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    University of Chinese Academy of Sciences, Beijing 100049, China
    More by Yihui Zhai
  • Pengcheng Zhang*
    Pengcheng Zhang
    State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    *E-mail: [email protected]
  • , and 
  • Yaping Li*
    Yaping Li
    State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    *E-mail: [email protected]
    More by Yaping Li
Cite this: ACS Nano 2018, 12, 3, 2789–2802
Publication Date (Web):February 20, 2018
https://doi.org/10.1021/acsnano.7b09210
Copyright © 2018 American Chemical Society
Article Views
3585
Altmetric
-
Citations
LEARN ABOUT THESE METRICS

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

Read OnlinePDF (3 MB)
Supporting Info (1)»

Abstract

Abstract Image

Triple-negative breast cancer (TNBC) tumors are heterogeneous, with mesenchymal-like cells at their core and fast proliferating cells on the periphery. It is desirable and beneficial to treat TNBC cells of different phenotypes with the most appropriate drugs. Here, we report a 78 nm, chlorin e6-, docetaxel-, and anti-Twist siRNA-containing polymeric nanoparticle (CDTN) with spatiotemporally specific activity when irradiated by light. Under conditions mimicking superficial tumor tissue with sufficient light input, TNBC cells are mainly killed by the photodynamic therapy (PDT) function of CDTNs. In contrast, under conditions mimicking deep tumor tissue with weak light input, PDT potentiates chemotherapy (CT) and gene therapy (GT) by facilitating the endolysosomal escape of CDTNs. Compared with free drugs, CDTNs improve the intratumoral exposure of docetaxel and anti-Twist siRNA by 2.5- and 2-fold, respectively. When combined with laser irradiation applied at the time of maximal intratumoral accumulation, the CDTNs significantly inhibit the growth of primary tumors and their lung metastasis (both >80%) by killing the peripheral cells, mainly through PDT and prohibiting the growth and metastasis of deep cells through PDT as enhanced CT and GT. On the contrary, dual-modality nanomedicine lacking CT, GT, or PDT showed fast primary tumor growth, poor metastasis control, or both, respectively. This study reveals the spatiotemporally specific mechanism of CDTNs in treating metastatic TNBC and highlights the importance of combined therapy in treating TNBC.

Supporting Information

ARTICLE SECTIONS
Jump To

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsnano.7b09210.

  • 1H NMR spectrum, CMC result, DLS results, Western-blotting images, drug release profiles, electrophoresis image, fluorescence images, combination index analysis, scratch closure and migration assays, biodistribution data, and histological analysis (PDF)

Terms & Conditions

Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

Cited By


This article is cited by 21 publications.

  1. Yang Dong, Hongze Liao, Hao Fu, Jian Yu, Qianqian Guo, Qi Wang, Yourong Duan. pH-Sensitive Shell–Core Platform Block DNA Repair Pathway To Amplify Irreversible DNA Damage of Triple Negative Breast Cancer. ACS Applied Materials & Interfaces 2019, 11 (42) , 38417-38428. https://doi.org/10.1021/acsami.9b12140
  2. Yu Xia, Guoyi Tang, Min Guo, Tiantian Xu, Haiyang Chen, Zhengfang Lin, Yinghua Li, Yi Chen, Bing Zhu, Hongsheng Liu, Jie Cao. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo. Materials Science and Engineering: C 2020, 110 , 110594. https://doi.org/10.1016/j.msec.2019.110594
  3. Li Zhang, Shiyu Zhang, Huajian Chen, Yu Liang, Bingxia Zhao, Wanxian Luo, Qian Xiao, Jinheng Li, Junqiao Zhu, Chao Peng, Yaru Zhang, Zhe Hong, Ying Wang, Yingjia Li. An acoustic/thermo-responsive hybrid system for advanced doxorubicin delivery in tumor treatment. Biomaterials Science 2020, 8 (8) , 2202-2211. https://doi.org/10.1039/C9BM01794A
  4. Xiaoye Yang, Xiaoqun Shi, Yanan Zhang, Jiangkang Xu, Jianbo Ji, Lei Ye, Fan Yi, Guangxi Zhai. Photo-triggered self-destructive ROS-responsive nanoparticles of high paclitaxel/chlorin e6 co-loading capacity for synergetic chemo-photodynamic therapy. Journal of Controlled Release 2020, https://doi.org/10.1016/j.jconrel.2020.04.027
  5. Mauricio A. Medina, Goldie Oza, Ashutosh Sharma, L.G. Arriaga, José Manuel Hernández Hernández, Vincent M. Rotello, Jose Tapia Ramirez. Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies. International Journal of Environmental Research and Public Health 2020, 17 (6) , 2078. https://doi.org/10.3390/ijerph17062078
  6. Chao He, Luodan Yu, Li Ding, Yu Chen, Yongqiang Hao. Self‐Assembled/Drug‐Composed Nanomedicine for Synergistic Photonic Hyperthermia and Targeted Therapy of Breast Cancer by Inhibiting ERK, AKT, and STAT3 Signaling Cascades. Advanced Functional Materials 2020, 2017 , 1908907. https://doi.org/10.1002/adfm.201908907
  7. Marco Cordani, Raffaele Strippoli, Álvaro Somoza. Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment. Cancers 2020, 12 (1) , 25. https://doi.org/10.3390/cancers12010025
  8. Cong Wang, Wenpei Fan, Zijian Zhang, Yu Wen, Li Xiong, Xiaoyuan Chen. Advanced Nanotechnology Leading the Way to Multimodal Imaging‐Guided Precision Surgical Therapy. Advanced Materials 2019, 31 (49) , 1904329. https://doi.org/10.1002/adma.201904329
  9. Shiwei Niu, Gareth R. Williams, Jianrong Wu, Junzi Wu, Xuejing Zhang, Xia Chen, Shude Li, Jianlin Jiao, Li-Min Zhu. A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy. Journal of Nanobiotechnology 2019, 17 (1) https://doi.org/10.1186/s12951-019-0529-4
  10. Benjamin D White, Chengchen Duan, Helen E Townley. Nanoparticle Activation Methods in Cancer Treatment. Biomolecules 2019, 9 (5) , 202. https://doi.org/10.3390/biom9050202
  11. Kapil D. Patel, Rajendra K. Singh, Hae-Won Kim. Carbon-based nanomaterials as an emerging platform for theranostics. Materials Horizons 2019, 6 (3) , 434-469. https://doi.org/10.1039/C8MH00966J
  12. Enhui Zhang, Ronge Xing, Song Liu, Pengcheng Li. Current advances in development of new docetaxel formulations. Expert Opinion on Drug Delivery 2019, 16 (3) , 301-312. https://doi.org/10.1080/17425247.2019.1583644
  13. Mengru Wang, Wanhua Liu, Yanqiu Zhang, Meng Dang, Yunlei Zhang, Jun Tao, Kun Chen, Xin Peng, Zhaogang Teng. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer. Journal of Colloid and Interface Science 2019, 538 , 630-637. https://doi.org/10.1016/j.jcis.2018.12.032
  14. Akshayya Pawar, Priyanka Prabhu. Nanosoldiers: A promising strategy to combat triple negative breast cancer. Biomedicine & Pharmacotherapy 2019, 110 , 319-341. https://doi.org/10.1016/j.biopha.2018.11.122
  15. Arsen Sheverdin, Constantinos Valagiannopoulos. Core-shell nanospheres under visible light: Optimal absorption, scattering, and cloaking. Physical Review B 2019, 99 (7) https://doi.org/10.1103/PhysRevB.99.075305
  16. Chaolong Wu, Xiaoyu Huang, Yunyun Tang, Wanyue Xiao, Liguo Sun, Jinjun Shao, Xiaochen Dong. Pyrrolopyrrole aza-BODIPY near-infrared photosensitizer for dual-mode imaging-guided photothermal cancer therapy. Chemical Communications 2019, 55 (6) , 790-793. https://doi.org/10.1039/C8CC07768A
  17. Yudong Xue, Jia Tian, Lei Xu, Zhiyong Liu, Yongjia Shen, Weian Zhang. Ultrasensitive redox-responsive porphyrin-based polymeric nanoparticles for enhanced photodynamic therapy. European Polymer Journal 2019, 110 , 344-354. https://doi.org/10.1016/j.eurpolymj.2018.11.033
  18. Xiaoqing Yi, Jun Dai, Yingyan Han, Min Xu, Xiaojin Zhang, Shijie Zhen, Zujin Zhao, Xiaoding Lou, Fan Xia. A high therapeutic efficacy of polymeric prodrug nano-assembly for a combination of photodynamic therapy and chemotherapy. Communications Biology 2018, 1 (1) https://doi.org/10.1038/s42003-018-0204-6
  19. Ya Wang, Xiaoyu Huang, Yunyun Tang, Jianhua Zou, Peng Wang, Yewei Zhang, Weili Si, Wei Huang, Xiaochen Dong. A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy. Chemical Science 2018, 9 (42) , 8103-8109. https://doi.org/10.1039/C8SC03386B
  20. Yihui Zhai, Wei Ran, Jinghan Su, Tianqun Lang, Jia Meng, Guanru Wang, Pengcheng Zhang, Yaping Li. Traceable Bioinspired Nanoparticle for the Treatment of Metastatic Breast Cancer via NIR-Trigged Intracellular Delivery of Methylene Blue and Cisplatin. Advanced Materials 2018, 30 (34) , 1802378. https://doi.org/10.1002/adma.201802378
  21. Zuozhong Liang, Zhiyuan Yang, Haitao Yuan, Chun Wang, Jing Qi, Kaiqiang Liu, Rui Cao, Haoquan Zheng. A [email protected]–organic framework nanocomposite for pH-triggered anticancer drug delivery. Dalton Transactions 2018, 47 (30) , 10223-10228. https://doi.org/10.1039/C8DT01789A

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

OOPS

You have to login with your ACS ID befor you can login with your Mendeley account.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect

This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.

CONTINUE